According to Immatics's latest financial reports the company's current EPS (TTM) is -$1.19. In 2022 the company made an earnings per share (EPS) of $0.73 an increase over its 2021 EPS that were of -$1.72.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$1.19 | -263.91% |
2022 | $0.73 | -142.4% |
2021 | -$1.72 | -50.65% |
2020 | -$3.48 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
Nymox Pharmaceutical NYMX | -$0.06000 | -94.97% | Bahamas |
NRC Health
NRC | $1.19 | -199.82% | ๐บ๐ธ USA |